acetylcysteine has been researched along with biliatresone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, I; Gillespie, K; Koo, KA; Lorent, K; Marchione, DM; Pack, M; Porter, JR; Shin, D; So, J; Waisbourd-Zinman, O; Wells, RG; Wilkins, BJ; Zhao, X | 1 |
| Blair, IA; Devoto, M; Escobar-Zarate, D; Estrada, MA; Gillespie, K; Loomes, KM; Lorent, K; Mesaros, C; Pack, M; Rajagopalan, R; Spinner, NB; Winkler, JD; Zhao, X | 1 |
2 other study(ies) available for acetylcysteine and biliatresone
| Article | Year |
|---|---|
Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish.
Topics: Acetylcysteine; Animals; Animals, Genetically Modified; Benzodioxoles; Biliary Atresia; Disease Models, Animal; Glutathione; Hepatocytes; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Liver; NF-E2-Related Factor 2; Oxidation-Reduction; Sulfoxides; Zebrafish | 2016 |
Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia.
Topics: Acetylcysteine; Animals; Animals, Genetically Modified; Benzodioxoles; Bile Ducts; Biliary Atresia; Cell Line; Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Free Radical Scavengers; Glutathione; Humans; Oxidation-Reduction; Proteostasis; Signal Transduction; Zebrafish | 2020 |